Company News
Emcure Subsidiary Gennova Sells mRNA Business for ₹1,395M
Emcure discloses subsidiary Gennova's slump sale of its mRNA business to Immunoscript Life Science for ₹1,395 million cash consideration.
The divested unit contributed ₹647.10 million revenue (0.71% o
